Altimmune, Inc.

ALT
NASDAQ
Company profile


Market capNano (26.99M)
Company CEOVipin K. Garg

Altimmune, Inc.

ALT
NASDAQ
Company profile


Market capNano (26.99M)
Company CEOVipin K. Garg
$1.76Price snapshot
-Annual dividend
N/ADividend yield
UnknownDividend growth (3y)
N/ATraling P/E
-Forward P/E
-Payout ratio
-EPS

ALT DIVIDEND PAYOUT HISTORY

Loading...

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

PRICE HISTORY Altimmune, Inc.

Loading price stock history...

Altimmune, Inc. latest news

Loading latest news...